Alex Puissant Lab

Thank you for a lovely visit! I learned so much and delighted in seeing great science done by such a friendly and inspired group. Thank you for the warm welcome!

Wonderful time with @landau_lab visiting us at @Institut_IRSL in Paris during his European tour to give an inspiring seminar on cutting-edge single-cell technologies. Thank you so much Dan for stopping by and see you soon! @camille_lobry @BenajibaLina

We are pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Leukaemia Research Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here:…

Wonderful time with @PaoloGallipoli visiting us at @Institut_IRSL to give an inspiring seminar on the role of fatty acid metabolism in leukemia. Thank you so much Paolo and see you soon

Abstract submission for the EHA Mol Hem workshop closes on Fri 11th at 5pm CEST. Don't miss your chance to showcase your research in this well attended interactive setting at the @EHA_Hematology annual meeting in Milan ehaweb.org/congress/eha20…

Great to hear insights from @jaybradner in conversation with Ross Levine, chair of @MSKCancerCenter, on how academic & industry researchers can cooperate in translational research and drug discovery. #CancerInnovation #CancerResearch #MarkSymposium

We are looking for a new lab manager. It's a demanding job but an exciting one with lots of room for growth as a scientist and manager. Consider applying even if you are currently a senior tech but interesting in moving into a lab manager position. hhmi.wd1.myworkdayjobs.com/External/job/H…

Amazing time with @MarcusBuschbeck visiting us at @Institut_IRSL to give an outstanding seminar on chromatin biology in leukemia. Thank you Marcus and see you soon!!!

After many years of explaining trainees how to review scientific manuscripts well, I've summarized them here: docs.google.com/document/d/1oZ…

Happy TRTH to the 2025 class! Want to join a fantastic mentoring program sponsored by @EHA_Hematology and @ASH_hematology, benefit from world-leader experts, and build a network in hematology? This is your best move of the day: apply for 2026!

It is an honor to be a part of the excellent #myeloicmalignancies25conference. The scientific program is stellar, the venue is stunning . Check it out! There is still time to register:

We are looking for a talented postdoctoral bioinformatician ⁦@TheDawsonLab⁩ to work with us on single cell multiomics incorporating lineage tracing and spatial technologies- we specifically want someone curious, fearless with a licence to innovate!! nature.com/naturecareers/…

PI3King on leukemia: Targeting PI3K and related vulnerabilities is a promising avenue in the treatment of leukemia. Recent studies by @lane_andy and @LabPuissant provided strong rationale for exploiting PI3Kgamma dependency in AML, paving the way for new PI3K-directed therapies.

Amazing collection of reviews on developmental hematopoiesis from leaders in the field. Just out in @ISEHSociety journal, Experimental Hematology exphem.org/content/editor…

Read the paper featured on the cover of this month’s Cancer Discovery: PKN2 Is a Dependency of the Mesenchymal-like Cancer Cell State brnw.ch/21wR7NC By Shane Killarney, @kcw00d, and colleagues @Duke_PCB @DukeCancer

L’Inserm est solidaire du mouvement Stand Up For Science 👉presse.inserm.fr/cest-dans-lair… #StandUpForScience2025

We are still looking for a lab technician with experience in mouse experiments! Apply to join our dynamic team and contribute to better understanding of blood development and leukemia! 🩸🐁

Targeting PI3Kγ in cancer pubmed.ncbi.nlm.nih.gov/39947962/

@jobRxiv Find the full job description here: jobrxiv.org/job/saint-loui…